Annex

United Kingdom

The entry corresponding to fenbendazole in Table 1 of the Annex to Regulation (EU) No 37/2010 is replaced by the following:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification
‘Fenbendazole Sum of extractable residues which may be oxidised to oxfendazole sulfone All food-producing species except fin fish 50 μg/kg Muscle For porcine and poultry species the fat MRL relates to “skin and fat in natural proportions” Antiparasitic agents/Agents against endoparasites’
50 μg/kg Fat
500 μg/kg Liver
50 μg/kg Kidney
10 μg/kg Milk
1 300 μg/kg Eggs

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic Classification
‘Fenbendazole	Sum of extractable residues which may be oxidised to oxfendazole sulfone	All food-producing species except fin fish	50 μg/kg	Muscle	For porcine and poultry species the fat MRL relates to “skin and fat in natural proportions”	Antiparasitic agents/Agents against endoparasites’
			50 μg/kg	Fat
			500 μg/kg	Liver
			50 μg/kg	Kidney
			10 μg/kg	Milk
			1 300 μg/kg	Eggs